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Abstract. 
 
Cells migrating within tissues may encounter 
multiple chemoattractant signals in complex spatial and 
temporal patterns. To understand leukocyte navigation 
in such settings, we have explored the migratory behav-
ior of neutrophils in model scenarios where they are 
presented with two chemoattractant sources in various 
configurations. We show that, over a wide range of con-
ditions, neutrophils can migrate “down” a local 
chemoattractant gradient in response to a distant gradi-
ent of a different chemoattractant. Furthermore, cells 
can chemotax effectively to a secondary distant agonist 
after migrating up a primary gradient into a saturating, 
nonorienting concentration of an initial attractant. To-
gether, these observations suggest the potential for 
cells’ step-by-step navigation from one gradient to an-
other in complex chemoattractant fields. The impor-
tance of such sequential navigation is confirmed here in 
a model system in which neutrophil homing to a de-
fined domain (
 
a
 
) requires serial responses to agonists 
presented in a defined spatial array, and (
 
b
 
) is a func-
tion of both the agonist combination and the sequence 
in which gradients are encountered. We propose a mul-
tistep model of chemoattractant-directed migration, 
which requires that leukocytes display multiple 
chemoattractant receptors for successful homing and 
provides for combinatorial determination of microenvi-
ronmental localization.
 
C
 
ells 
 
migrating in a tissue encounter many different
signals that can potentially direct their path. Neu-
ronal migration is a well-characterized example;
neurons weave a lengthy, tortuous, and precise path
through the body as they are guided by attractants, repel-
lents, and adhesion molecules. This complex task is simpli-
fied because cells travel in a series of short trajectories, ne-
gotiating direction at “choice points” along their journey
(21). Like neurons, cells of the immune system require
very accurate positioning within tissues to perform their
biological functions. However, little is known about how
leukocytes navigate through the complex environments
they encounter upon entering a lymphoid organ or target
tissue. In this study, we investigate how leukocytes behave
in complex migratory environments. We have focused on
one class of leukocyte guidance cues—the increasingly di-
verse family of leukocyte chemoattractants.
The number of known leukocyte attractants has ex-
panded in recent years with the discovery of increasing
numbers of chemokines (for review see 14, 16). Like classi-
cal leukocyte attractants, chemokines are small molecules
that bind to G protein–coupled receptors on leukocytes
and mediate directional migration when presented in a con-
centration gradient. Each leukocyte type has the capacity
to respond to multiple different chemokines and/or classi-
cal attractants. Furthermore, many of the attractants that
act on a given cell may be present together in a leukocyte-
recruiting tissue. One classical example is a site of bacterial
infection, in which a variety of neutrophil chemoattrac-
tants are produced by different sources: host endothelial,
epithelial, and stromal cells produce arrays of attractants
including interleukin-8 (IL-8)
 
1
 
, GRO-
 
a
 
, and others; com-
plement deposition on pathogens releases the attractant C5a;
invading bacteria generate N-formyl peptides, which are
neutrophil attractants; and activated neutrophils them-
selves produce attractants (for review see reference 8). Re-
cent reports reveal many analogous examples of differen-
tial chemokine expression by different cell types in a range
of leukocyte-recruiting tissues (1, 9, 10, for review see ref-
erences 19, 25). Therefore, once it has entered a tissue, a
leukocyte requires mechanisms to integrate the various di-
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Abbreviations used in this paper
 
: EC
 
50
 
, 50% effective concentration;
fMLP, N-formyl peptide fMet-Leu-Phe; IL-8, interleukin-8; LTB4, leuko-
triene B4.
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rectional signals it receives from different attractants such
that it arrives at its correct destination.
Heterologous desensitization of chemoattractant recep-
tors may be one important mechanism whereby migrating
cells integrate information from different chemoattrac-
tants (4, 12). Several studies have shown that treating leu-
kocytes with certain chemoattractants diminishes the cells’
ability to respond to other attractants. Responses to one
attractant that can be suppressed by others include intra-
cellular signaling events (7, 17, 18, 22, 26), cell adhesion
(4), orientation (6), actin polymerization (12), and cell mi-
gratory behavior (4, 12). Based on observations in neutro-
phils, we postulated that this cross-inhibition of migratory
responses might allow cells to prioritize signals from their
end targets over more general recruitment signals from
host cells (4).
In this study, we investigate the decision making pro-
cesses whereby leukocytes navigate through complex fields
of overlapping chemoattractant gradients, such as those
cells might encounter within tissues. We focus on the spa-
tial guidance of cells through different agonist arrays, in
situations that do not involve cross-inhibition as well as in
situations that do. We use neutrophils as a model of leuko-
cyte migratory behavior. We have examined neutrophils’
responses to four well-characterized attractants produced
at sites of inflammation, focusing not only on the regula-
tory cell–derived lipid leukotriene B4 (LTB4) and the
chemokine IL-8, but also including the “classical,” end tar-
get–derived attractants, bacterial-derived formyl peptides
and complement fragment C5a. Based on our observa-
tions, we propose that leukocytes can navigate through
complex chemoattractant fields by migrating in a step-
by-step manner in response to one agonist source after an-
other, so that their ultimate positions are determined com-
binatorially by the array of receptors they express and by
the sequence of chemoattractant gradients they encounter.
 
Materials and Methods
 
Cell Preparation
 
Blood was collected from healthy adult volunteers. Neutrophils were pre-
pared using conventional 1% dextran sedimentation to remove erythro-
cytes, followed by Ficoll density gradient centrifugation (Pharmacia Bio-
tech Sevrage, Uppsala, Sweden). Residual erythrocytes were lysed by
resuspending in hypotonic salt solution (0.2% NaCl), followed by hyper-
tonic rescue (equivolume 1.6% NaCl). The resulting granulocyte prepara-
tion was 
 
>
 
95% neutrophils as assessed by histological staining. Neutro-
phils were resuspended at 10
 
7
 
 cells/ml in migration medium (see below)
and kept on ice until the start of the assay. All procedures were performed
with endotoxin-free solutions.
 
Under-agarose Assay
 
Agarose Gel. 
 
The procedures of Nelson et al. (see reference 15) were
adapted for our experiments. Falcon 3001 tissue culture dishes (Falcon
Plastics, Cockeysville, MD) were filled with 3 ml each of an agarose solu-
tion (50:50 HBSS/H
 
2
 
CO
 
3
 
-buffered RPMI-1640 (Sigma Chemical Co., St.
Louis, MO), 10% heat-inactivated bovine calf serum, 1.2% agarose
(GIBCO BRL, Gaithersburg, MD). After the gel had solidified, the bicar-
bonate-buffered plates were allowed to equilibrate to physiological tem-
perature and pH in a 37
 
8
 
C CO
 
2
 
 incubator.
Wells were cut in the standard configurations as follows. Guided by a
template, 3.5-mm-diam holes were cut 2.2 mm apart in the agarose gel, us-
ing a plastic pipette tip attached to a vacuum line to remove the cylindrical
plugs.
 
Migration Medium. 
 
Cells and agonists were suspended in RPMI-1640 
 
1
 
10% heat-inactivated bovine calf serum (serum inactivated at 57
 
8
 
C, 25
min).
 
Chemoattractants. 
 
f-Met-Leu-Phe (Sigma Chemical Co.), recombinant
human complement fragment C5a (Sigma Chemical Co.), LTB4 (Sigma
Chemical Co.), and recombinant human IL-8, a gift from A. Rot (Sandoz
Forschungsinstitut, Vienna, Austria).
 
Preparations for Video Microscopy. 
 
For video microscopy, agarose plates
were prepared as described, but with 1.2% agarose in RPMI-1640 without
bicarbonate (Sigma Chemical Co.), 10 mM Hepes, pH 7.4, and 10% heat-
inactivated bovine calf serum. Migration assays were performed in a hu-
midified chamber, kept at 37
 
8
 
C with a stage warmer.
 
Assay Procedures
 
At the start of the standard migration assay, four “cell wells” (experimen-
tal wells containing cells) surrounding a central attractant well were each
filled with 10
 
5
 
 neutrophils (vol 
 
5
 
 10 
 
m
 
l). 10 
 
m
 
l of chemoattractant was
placed in the central well, and 10 
 
m
 
l of medium alone was placed in four
peripheral control wells. The same results were obtained when only two
cell wells, on either side of the attractant well, were filled, indicating that
our results do not reflect interactions between cells in different cell wells
on a plate. Once plates were filled with cells and attractant, they were al-
lowed to incubate in a 37
 
8
 
C CO
 
2
 
 incubator for the times indicated in the
Results section. No directional migration was seen towards medium only
in peripheral control wells.
To test whether cells could migrate away from a local agonist source in
response to a distant one, 10 
 
m
 
l of neutrophils (10
 
5
 
) and 10 
 
m
 
l of chemoat-
tractant were placed together into each cell well (total vol 
 
5
 
 20 
 
m
 
l), with
10 
 
m
 
l of chemoattractant in the central attractant well. To test the re-
sponses of cells to two gradients in sequence, wells on either side of the
central attractant well were filled with 10
 
5
 
 neutrophils (vol 
 
5
 
 10 
 
m
 
l). The
central attractant well and a well 2.2 mm to its side (90
 
8
 
 from the cell well)
were filled with attractant or medium only at 
 
t
 
 
 
5
 
 0 and refilled at 
 
t
 
 
 
5
 
 1.5 h.
Peripheral control wells were filled with medium only. After a 3-h incuba-
tion, plates were flooded with methanol.
 
Fixation and Staining. 
 
Plates were fixed with methanol for 
 
.
 
30 min,
followed by 37% formaldehyde for 
 
.
 
30 min. Agarose gels were removed
and cells, now fixed to the plate, were stained using Field’s rapid stain
(Gallard-Schlessinger Chemical Manufacturing, Long Island, NY). The
distance from the edge of the cell well to the leading edge of the migrating
cell front was measured with the aid of a magnifier and reticle. Cell num-
bers in specified regions were quantitated using a transparent template at-
tached to the bottom of the plate, with plates projected onto a television
screen to facilitate counting.
 
Measurement of Gradients
 
One 3.5-mm-diam hole was cut in the center of the same type of agarose-
filled tissue culture dish used for migration assays. The well was filled with
20 
 
m
 
l of solution containing either 0.25 pmol (0.5 
 
m
 
Ci) of 
 
125
 
I-labeled IL-8
(Amersham Corp., Arlington Heights, IL), diluted into migration me-
dium, or 25 pmol of [
 
3
 
H]LTB4 (0.5 
 
m
 
Ci; Amersham Corp.). Plates were al-
lowed to incubate at 37
 
8
 
C in the CO
 
2
 
 incubator for 30–120 min. After
incubation, liquid remaining in the well was removed, and several 1.7-
mm-wide strips of agarose were cut radially from the edge of the well to-
wards the perimeter of the plate, using two parallel razor blades attached
to a spacer. Strips were treated as specimens for frozen section, as in refer-
ence 24. Serial 60-
 
m
 
m cross-sections were cut from the strip using a micro-
tome cryostat (International Equipment Co., Needham, MA), collected,
and then radioactivity in each group of four sections was quantitated using
a gamma counter for 
 
125
 
I (Gamma 4000; Becton and Dickinson Co.,
Mountain View, CA) or Scintillation counter for [
 
3
 
H]LTB4 (LS1801, Bec-
ton and Dickinson Co.). For these determinations, the 60-
 
m
 
m thickness of
cryostat sections was confirmed by two methods: (
 
a
 
) an agarose gel of de-
fined width and height was permeated by a known amount of evenly dis-
tributed radioactive IL-8. This block was sectioned as above, and the
length of each section was calculated based on the volume of each slice, as
indicated by the cpm. (
 
b
 
) A series of blocks of defined length (1.7 mm, cut
with razor blade device) were sectioned as above. The mean number of
slices to cut a 1.7-mm distance was 29 (1,700/29 
 
5
 
 58.6 
 
m
 
m).
Sources of experimental imprecision in the measurements used for gra-
dient calculations include: (
 
a
 
) the standard deviation in cpm for “identi-
cal” 60-
 
m
 
m slices is 
 
z
 
15% of the mean. This may include imprecision in
section thickness and/or in gamma counter readings. (
 
b
 
) The standard de- 
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viation in size of 1.7-mm strips, cut as described, is 
 
z
 
12% of the mean. (
 
c
 
)
The standard deviation in the amount of labeled compound added to each
starting well, with a Hamilton syringe, is 
 
,
 
3% of the mean.
To determine where the edge of the chemoattractant well was during
sectioning, we stained the edges of several wells with India ink, cut strips
starting at these wells, and prepared them for frozen sectioning as above.
The first 60-
 
m
 
m section that lacked visible India ink was taken to repre-
sent the first 60 
 
m
 
m of agarose for the gradient plots in Fig. 2.
 
Gradient Calculations
 
The cpm of the IL-8 or LTB4 added to the agonist well, and the cpm in
sections of agarose at known distances from the starting well were deter-
mined. The volume of each group of four 60-
 
m
 
m sections (a “240-
 
m
 
m
block”) was known to be 0.17 cm 
 
3
 
 0.2095 cm 
 
3
 
 0.024 cm. Using this in-
formation, the amount of radiolabeled compound in each 240-
 
m
 
m block
was calculated, allowing calculation of the mean agonist concentration in
each block as a function of the amount of agonist added.
We determined the change in the agonist concentration per mm or per
cell length as follows: for each gradient, plots of the log agonist concentra-
tion vs. distance from the agonist source well displayed a close fit to a
straight line, so that the gradient profiles followed the exponential func-
tion:
where 
 
C
 
 
 
5
 
 concentration at a given distance, 
 
D
 
, from the agonist well, and
 
k
 
 
 
5
 
 a constant. This equation is consistent with free diffusion from a
broad front. The slope of each gradient profile on a semi-log plot (
 
d
 
log
 
C
 
/
 
dD
 
) was used to determine the fold change in concentration for a given
change in distance for 
 
D
 
D
 
 
 
5
 
 1 mm, or for 
 
D
 
D
 
 
 
5
 
 10 
 
m
 
m (approximately
one cell length). Fold concentration change over a given distance 
 
D
 
D
 
 was
calculated as 10
 
slope
 
 
 
3
 
 
 
D
 
D
 
.
 
Results
 
To model the migratory responses of neutrophils navigat-
ing within a tissue, we used an “under-agarose” neutrophil
migration assay (15). In this system, a chemoattractant is
introduced into a well in the agarose, and cells migrate to-
wards the attractant. We chose this system rather than a
conventional Boyden chamber–type assay because attrac-
tant-containing wells can be introduced in a variety of spa-
tial configurations in the “plane” of the tissue culture dish,
and therefore this system can be used to study cellular re-
sponses to a complex chemotactic field with two (or more)
chemotactic gradients overlapping in different spatial ar-
rays. Furthermore, this system permits ready visual assess-
ment of the distance and direction of neutrophil migration
in two dimensions.
 
Migration Down a Local Concentration Gradient
 
Given the multiple cell types that produce leukocyte
chemoattractants, leukocytes responding to a distant at-
tractant from a target site may often be faced with the di-
lemma of having to migrate away from a local agonist
source to reach their destination. To model this situation
in the under-agarose assay, we placed neutrophils together
with various concentrations of a primary agonist in one
well (well 1), and assessed their ability to migrate away
from the primary source towards a distant source of the
same or of a different chemoattractant (in well 2). Addi-
tion of IL-8 to the well containing neutrophils efficiently
inhibited chemotaxis towards a distant IL-8 source, as ex-
pected (Fig. 1, 
 
a
 
 and 
 
b
 
). In contrast, addition of LTB4 to
the cell well had little or no effect on migration to IL-8;
only at the highest LTB4 doses was there a minimal effect
on the distance of neutrophil migration to IL-8 (Fig. 1, 
 
a
Ck 10
D ´ =
 
and 
 
b
 
). Similarly, placing LTB4 with cells in well 1 inhib-
ited migration to a distant LTB4 source (well 2), but neu-
trophils migrated efficiently away from a local IL-8 source
towards the distant lipid attractant (Fig. 1, 
 
a
 
 and 
 
c
 
). Thus
neutrophils can readily migrate from a well containing a
primary agonist towards a distant secondary attractant well.
That responding neutrophils are in fact migrating down
a local gradient during this assay was confirmed by mea-
suring the IL-8 and LTB4 gradients, using radioactively la-
beled IL-8 and LTB4. IL-8 gradient measurements were very
consistent, in shape and magnitude, whereas LTB4 gradi-
ent measurements were more variable, especially in mag-
nitude. As illustrated in Fig. 2 
 
a
 
, an inverse IL-8 gradient is
present from 30 min (the earliest time point measured),
and the inverse gradient is maintained over the entire 2-h
time course of the assay. The mean IL-8 concentration
near the source well does not decrease over this time, pre-
sumably reflecting sustained diffusion of IL-8 into the aga-
rose (some fluid remains in the well for at least 60 min
after the start of the assay). An LTB4 gradient is also
present throughout the entire assay, consistent with previ-
ous studies (24) (Fig. 2, 
 
b
 
 and 
 
c
 
). Unlike the IL-8 gradient,
the mean concentration of the LTB4 near well 1 decreases
with time, suggesting that LTB4 diffuses faster than IL-8.
Although LTB4 levels have decreased by 120 min, a gradi-
ent from the source well is still present (Fig. 2 
 
c
 
).
Neutrophils’ ability to orient in a gradient of chemoat-
tractant is a function of two parameters: gradient steep-
ness (fold concentration change/cell length) and mean ag-
onist concentration (6, 23, 27, 28). In our experiment, the
steepness of the inverse IL-8 gradient ranges from a 20-
fold change per mm (1.026-fold/cell length) at 30 min to a
fourfold change per mm (1.016-fold/cell length) at 120 min;
fold concentration change was calculated as described in
Materials and Methods. The inverse LTB4 gradient shape
ranges from a decrease of eightfold/mm (1.02-fold/cell
length) at 30 min to twofold/mm at 120 min. Furthermore,
for all gradients measured, the gradient profile approxi-
mates an exponential curve, meaning that the fold concen-
tration change per mm is the same throughout the gradient.
Other studies have shown that neutrophils can orient well
in response to these concentration differentials; orientation
occurs, even at nonoptimal agonist concentrations (10-fold
above or below the receptor dissociation constant), in a
more than threefold/mm gradient, and can occur at opti-
mal agonist levels (near the receptor dissociation constant)
in a gradient that changes only twofold/mm (1.007-fold/
cell length) (27). In addition to these quantitative consid-
erations, the efficient migration towards IL-8 or LTB4 ob-
served in our assays confirms that the steepness of these
gradients is in a relevant range for eliciting directional mi-
gration.
The ability of neutrophils to migrate down, and appar-
ently largely ignore, the gradients arising from their start-
ing well is also largely independent of the concentration
range of the inverse gradients. When cells are placed with
1 pmol of IL-8, the mean concentration at 30 min in the
first 0.5 mm of the gel is 10 nM, about 10 times the concen-
tration at which half of the cells’ IL-8 receptors are occu-
pied and 10 times the 50% effective concentration (EC
 
50
 
)
for migration to IL-8 in a filter assay (Millipore Corp., Wa-
ters Chromatography, Bedford, MA) (2, 13). As shown in 
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Fig. 1 
 
b
 
, cells migrate just as effectively away from the IL-8
source towards an optimal dose of LTB4 when the mean
IL-8 concentration near the cell well is one, two, or three
orders of magnitude less (at 1, 0.1, or 0.01 times the con-
centration for half-receptor occupancy). This range clearly
spans concentrations expected to be optimal for directing
cell orientation and migration. For example, neutrophils
migrating away from a 0.1 pmol IL-8 source are moving
against a 20-fold/mm gradient with a mean concentration
of about 1 nM at 30 min (when they are still near the cell
well), and a 7-fold/mm gradient with a mean concentration
of 2 nM at 90 min (when the leading edge has migrated
roughly 1 mm under these conditions). Neutrophils can
migrate away from an LTB4 source over a wide range of
LTB4 concentrations as well, from concentrations corre-
sponding to 50–100 times half-receptor occupancy and
chemotactic EC
 
50
 
 in a Boyden chamber (1–3 nM) (11), to
at least three orders of magnitude below the chemotactic
EC
 
50
 
 (Fig. 1 
 
c
 
). We conclude that, under a wide range of
conditions, leukocytes have the capacity to migrate away
from a nearby agonist source in response to a distant
chemoattractant.
One prediction from these studies would be that, if neu-
trophils were placed with IL-8 in one well, and other neu-
trophils with LTB4 in another well 2.2 mm away, the cells
should migrate in opposite directions with each cell popu-
lation responding to the agonist in the distant well. Fig. 3
illustrates traces of neutrophils migrating from an IL-8 to
an LTB4 source or (in the opposite direction) from the
LTB4 source to the IL-8 source, over a 15-min period
(105–120 min) as they approach a midpoint between the
two source wells. The traces emphasize the striking, op-
posing directionality of chemotactic migration of the two
populations as they come together.
The cells’ ability to ignore a local agonist source to re-
spond to a distant one is constrained by the dominance of
end target–derived attractants (N-formyl peptide fMet-
Leu-Phe [fMLP], C5a) over regulatory cell–derived attrac-
tants (IL-8, LTB4), in a manner consistent with previous
studies in other model systems (4, 6, 12). Whereas neutro-
phils could migrate away from a local IL-8 or LTB4 source
towards fMLP or C5a (Fig. 4, 
 
a
 
 and 
 
b
 
), cells originating
from a high local concentration of fMLP or C5a do not re-
spond efficiently to a distant source of IL-8 or LTB4. Lo-
Figure 1. Neutrophils mi-
grate away from one
chemoattractant source to-
wards another. (a) Photo-
graphs of stained neutro-
phils after 2-h migration
towards a distant source of
LTB4 or IL-8 (1 pmol), in
the presence or absence of an
inverse gradient generated
by LTB4 or IL-8 (10 pmol).
Cells placed with one ago-
nist migrate towards the
other agonist almost as well
as control cells, but do not
migrate well towards a dis-
tant source of the same ag-
onist. (b) Dose-response
curves illustrate that over a
wide range of concentrations
of both agonists, cells can mi-
grate away from an IL-8
source in response to a target
LTB4 gradient; however,
cells do not migrate away
from a well containing IL-8
(>1 pmol) towards a distant
IL-8 source. (c) Conversely,
over a wide concentration
range of close and distant ag-
onists, neutrophils migrate
away from an LTB4 source
towards IL-8, but not to-
wards LTB4. Each graph in b
and c shows the data from a
representative experiment
of at least two to five per-
formed with similar results.
Error bars in b and c indicate
the standard deviation of the
distance migrated for four
replicates. 
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cal fMLP also suppressed migration to a distant source of
C5a and, although less completely, C5a also suppressed
migration to fMLP (data not shown).
 
Migration beyond a Threshold High Dose
of Chemoattractant
 
Neutrophils migrating towards an agonist source necessarily
encounter increasing concentrations of agonist. In the under-
agarose assay, neutrophils migrating towards a greater-
than-optimal dose of chemoattractant appear to arrest and
collect upon entering a region of excessive agonist concen-
tration (Fig. 5) (5). At increasingly high doses, large num-
bers of cells continue to leave the cell well, but their migra-
tion is arrested at relatively discrete distances, with the
distance migrated being inversely related to the concentra-
tion of agonist added. These observations are consistent
with the well-known high dose inhibition of neutrophil ori-
entation and directed migration (for review see reference
6). Zigmond observes that neutrophils orienting in re-
sponse to a 10-fold/mm formyl peptide gradient begin to
become disoriented in a gradient with a mean peptide con-
centration  .10 times the peptide receptor dissociation
constant (27). Extrapolating from our gradient measure-
ments above, it is clear that the concentrations of agonist
at the position where the barrier forms exceed those re-
quired for receptor saturation. For IL-8, our gradient cal-
culations indicate that the position of the high dose disori-
entation “barrier” for cells migrating to 50 pmol IL-8
corresponds to a concentration range between 100 nM at
60 min, when the barrier is forming, and 400 nM at 120
min (extrapolated from Fig. 2 a; with concentrations multi-
plied 50-fold). Cells migrating to 50 pmol LTB4 form a
barrier at a position corresponding to z100 nM through-
out the assay. These measurements are consistent with the
prediction that the migration arrest we observe reflects
cell disorientation due to receptor saturation.
We asked if neutrophils that had reached the high dose
barrier to further migration could nonetheless migrate fur-
ther in response to a different attractant gradient (Fig. 6).
The distances of neutrophil migration over 2.5 h to various
concentrations of IL-8 are depicted in the bar graph in Fig.
6 a, illustrating the high dose barrier formation at z700
mm from the cell well when 50 pmol agonist is added. Half-
way through the assay (at 1.25 h), when the barrier has
formed, a lower dose of either IL-8 or LTB4 was intro-
duced into the agonist source well. Addition of more IL-8
did not permit further migration of cells, but addition of a
distinct attractant, LTB4, to the agonist well resulted in
cell reorientation and migration beyond the IL-8 barrier.
A representative experiment is illustrated in the lower
panel (Fig. 6 a); the number of cells entering a homing
“target zone” beyond the IL-8 barrier is given for each
condition depicted. In this 2.5-h assay, cells must migrate
first to IL-8, and then respond to the LTB4 added halfway
through the assay (at 1.25 h) to reach the target zone. Cells
that have not first migrated to IL-8 do not enter the target
zone, even if they experience the LTB4 gradient for 1.25 h.
In parallel experiments, neutrophils arrested in a high
dose barrier of LTB4 could be induced to migrate beyond
that barrier by the addition of low dose IL-8 (but not
LTB4) to the agonist well halfway through the assay. Fig. 6
b summarizes the data from this series of experiments.
Disorienting levels of the primary agonists are clearly re-
tained throughout the response to the secondary attrac-
tant, as indicated by the fact that a low dose of the primary
Figure 2. Gradients formed
by IL-8 and LTB4 and calcu-
lated agonist concentrations
for 1 pmol added in well 1.
Each curve shows a repre-
sentative of at least three de-
terminations of the IL-8 (a)
or LTB4 (b) concentration
gradients in agarose, 30–120
min after addition of radioac-
tive agonist, using the proto-
col outlined in the Materials
and Methods section. Repli-
cate IL-8 gradient measure-
ments were very consistent in
shape and magnitude, whereas
LTB4 gradient measurements
were more variable, especially
in magnitude. The concentra-
tions indicated were calculated
for a gradient generated by 1
pmol of agonist. (c) Two rep-
licate determinations of the
LTB4 gradient at 120 min.
Figure 3. Neutrophils can migrate in opposite directions in the
same field of overlapping chemoattractant gradients. The migra-
tory behavior of neutrophils placed in IL-8 (originating in a well
below the picture) and LTB4 (originating in a well above the pic-
ture) was recorded by time-lapse video microscopy. The image
shows cells at the leading edge of each population 90 min after
the start of the assay, when each population is nearing a common
point between the starting wells. Arrows indicate the migration
paths of several representative cells over the next 15 min. Most
cells that started at the IL-8 source migrate towards the LTB4
source and vice versa; occasionally, a cell is observed to change
directions (i.e., cell indicated by *).The Journal of Cell Biology, Volume 139, 1997 1354
agonist did not induce further migration when added half-
way through the assay. Moreover, even when the high
dose primary agonist was re-added halfway through the
assay along with the secondary agonist, the secondary ago-
nist could elicit migration into the target zone (data not
shown.) We conclude that leukocytes migrating up a pri-
mary gradient into disorienting agonist concentrations can
reinitiate directed locomotion in response to secondary
gradients at lower levels.
As expected, the capacity for a secondary agonist to in-
duce migration beyond the high dose barrier was con-
strained by the dominance of end target attractants; nei-
ther IL-8 nor LTB4 could induce migration into the target
zone when the primary agonist was fMLP (Fig. 6 c).
Step-by-step Navigation through Sequential 
Chemotactic Fields
The experiments outlined above demonstrate that leuko-
cytes can orient and chemotax efficiently to a distant at-
tractant even when migrating down a local attractant gra-
dient, or after migrating uphill into and beyond a saturating
and disorienting level of a primary agonist. This has fun-
damental implications for leukocyte navigation through
tissues, as it suggests that they should be able to migrate
sequentially from agonist source to agonist source in a multi-
step process.
To model this type of scenario, we assessed the behavior
of cells responding to attractants presented in two wells,
one “central” well located 2.2 mm from the cell well (as in
the previous assays), and the second “side” well positioned
at a 908 angle, 2.2 mm from the central well and 4.5 mm
from the cell well (Fig. 7 a). We defined an arbitrary target
zone, as illustrated in the figure, and asked whether neu-
trophils could be attracted to this target zone by chemoat-
tractants presented in various combinations in the primary
(central) and/or the more distant, secondary attractant
wells. All agonists were used at optimal chemoattractant
concentrations (defined for the proximal well, Fig. 7, leg-
end). As illustrated in Fig. 7 b, and shown quantitatively in
Fig. 7 c, cells migrated well in response to IL-8 in the cen-
tral well, but could not enter the target zone in significant
numbers. When IL-8, LTB4, or both were presented in the
side well only, cells were able to migrate a short distance
directly towards the side well, but did not enter the target
zone. When IL-8 was presented in both the central and
side wells, cells migrated only towards the closer central
well; this was not unexpected, as locally this would be seen
as “upgradient” in spite of the additional, more distant
source of the same agonist. Finally, when IL-8 was pre-
Figure 4. The migratory be-
havior of cells originating at
a source of fMLP or C5a. (a)
Photographs of stained cells
after 2-h migration to a source
of fMLP, IL-8, or LTB4 (1
pmol). Cells originating in a
well containing IL-8 or LTB4
(10 pmol) exhibit robust mi-
gration towards fMLP (top
row); however, cells placed
with fMLP (10 pmol) do not
migrate towards IL-8 or LTB4.
(b) Dose-response curves
show  the effect of varying
concentrations of fMLP and
C5a on migration to IL-8 and
LTB4, and the effect of vary-
ing amounts of IL-8 and
LTB4 on migration to fMLP
and C5a. Each graph shows
the data from a representa-
tive experiment of two to five
performed with similar re-
sults; error bars indicate the
standard deviation of the dis-
tance migrated for four repli-
cates.Foxman et al. Combinatorial Control of Leukocyte Chemotaxis 1355
sented in the central well and LTB4 was presented in the
side well, neutrophils were able to home to the target zone
in large numbers (Fig. 7, b and c).
Similar patterns were elicited with IL-8 and fMLP (Fig.
7, b and c). Only when the attractant in the secondary, side
well was distinct from the primary central IL-8 attractant
were cells able to localize in significant numbers to the tar-
get zone: when fMLP was presented in both the central
and the side wells, cells migrated towards the central well
only. However, when IL-8 was presented in the central
well and fMLP in the more distant side well, cells migrated
into the target zone. Tracing the position of the leading
edge of migrating neutrophils, shown in Fig. 7 d, demon-
strates that the successfully homing neutrophils migrate
initially towards the primary IL-8 source, and then turn as
they come in range of the secondary attractant allowing
their migration into the target region.
In this assay, as in the previous ones, the ability of neu-
trophils to respond to a secondary agonist is constrained
by the dominance of fMLP over IL-8. Although cells mi-
grate into the target zone when IL-8 is presented as the
central (proximal) agonist and fMLP is presented in the
side well, the converse is not true. Neutrophils migrate
well towards the central fMLP source, but do not turn in
response to the IL-8 in the side well (Fig. 7, b and c). Thus,
Figure 5. Dose dependence
of neutrophil migration un-
der agarose. Neutrophil re-
sponses to a range of IL-8
gradients in the standard 2-h
under-agarose migration as-
say are shown. Neutrophils in
the cell well migrate in re-
sponse to a concentration
gradient generated by the in-
dicated amounts of IL-8 in
the agonist well. On migrat-
ing towards gradients gener-
ated by .1 pmol IL-8, the
migrating front at the leading
edge is flat, and cells are
densely packed. The distance
cells migrate before arresting
in this configuration de-
creases as the IL-8 concen-
tration in the agonist well in-
creases. All chemoattractants
used in this study exhibit a
qualitatively similar dose-
response curve in this migra-
tion assay.
Figure 6. Neutrophils can migrate beyond a high dose barrier of
a primary agonist in response to a secondary agonist. (a–c) In a
standard migration assay, neutrophils were allowed to migrate to-
wards a gradient generated by an agonist dose high enough (50
pmol IL-8 or LTB4, 5 pmol fMLP) to arrest crawling cells in a flat
migrating front at a fixed distance from the agonist well. Halfway
through the assay (at 75 min), a lower dose of a second agonist (5
pmol IL-8 or LTB4) was added to the agonist well. The distances
cells migrated, in the presence or absence of the second agonist,
are graphed in the upper panels as the mean of four replicates, er-
ror bars showing the standard error. The dashed line shows the
position of the high dose migration barrier. Photographs show
cells that have migrated to a first agonist only for 150 min (bot-
tom left), the first agonist for the entire 150 min plus the second
agonist for the last 75 min (bottom center), or to the second ago-
nist only for 75 min (bottom right). The number of cells entering a
target zone near the agonist well are indicated (mean and range
of two replicates from a representative experiment).The Journal of Cell Biology, Volume 139, 1997 1356
in this model of sequential navigation, the targeting of
neutrophils is a function of both the chemoattractants and
receptors involved, and of the order in which the attrac-
tants are encountered by migrating cells.
Discussion
In the last several years, numerous novel leukocyte chemo-
attractant receptors and their ligands (especially chemo-
kines) have been identified. In general these receptors are
expressed in overlapping patterns by several leukocyte
subtypes, and each leukocyte subtype itself expresses mul-
tiple chemoattractant receptors (14, 16). Moreover, it is
clear that the attractants themselves are produced in di-
verse combinations by host cells in the setting of inflam-
mation, and by lymphoid and tissue stromal cells in sites of
constitutive lymphocyte trafficking. In the context of this
multiplicity and promiscuity of receptor and agonist ex-
pression, it has been difficult to formulate a unifying
model of how chemoattractants might participate in the
highly specific microenvironmental targeting of leukocyte
subpopulations observed in vivo. The mechanisms of cell
targeting by chemotaxis, of course, are not relevant only to
leukocyte homing but also to the migration of other cell
types during, for example, embryogenesis or neurogenesis.
To better understand the role of multiple attractants in
directing cell migration within tissues, we have examined
how a migrating leukocyte behaves when it encounters a
two-dimensional array of attractants for which it bears re-
ceptors. We used an in vitro model of neutrophil migration
Figure 7. Neutrophil navigation
targeted by sequential migration
to chemoattractants in a defined
spatial array. (a) Diagram illus-
trating the position of the two ag-
onist wells relative to the cell
well,  and the outline of the tar-
get zone used to quantitate the
number of cells migrating se-
quentially to both agonists (see
c). (b) Photographs of fixed,
stained cells that have been al-
lowed to migrate for 3 h in the
presence or absence of a central
agonist (right side of photos)
and/or side agonist (left side of
photos). The approximate posi-
tion of the target zone is indi-
cated in each image (for quanti-
tative analyses, target zones
were precisely positioned by a
template). Successfully homed
cells have been accentuated for
illustrative purposes by enhanc-
ing the contrast in the target re-
gion. The amounts of IL-8,
LTB4, and fMLP in the agonist
wells were 1 pmol, 1 pmol, and
0.5 pmol, respectively. (c) Graph
indicating the number of cells
migrating into the defined target
zone in presence of various ago-
nist combinations. The mean
number of cells entering the tar-
get zone is indicated. Error bars
show the range for two replicate
determinations from a represen-
tative experiment. Asterisks in-
dicate that the mean number of
cells in the target region was
,15. (d) Turning behavior of
cells migrating to two agonists in
sequence. Dots indicate the cen-
ter of the leading edge of mi-
grating cells at various times for
cells responding to a central IL-8
source and side LTB4 source
(top) or a central IL-8 source
and side fMLP source (bottom).Foxman et al. Combinatorial Control of Leukocyte Chemotaxis 1357
under agarose, a model that allowed us to focus on direc-
tional migration responses to chemoattractants in the ab-
sence of the numerous other factors, such as extracellular
matrix components and cells, which undoubtedly contrib-
ute to the regulation of cell navigation in vivo. Using this
model, we have examined simplified scenarios where neu-
trophils are exposed to defined spatial gradients of two
different neutrophil chemoattractants. Our findings lead
us to propose that leukocytes can progress through com-
plex, varying chemotactic fields in a series of steps with
different arrays of attractants combining to dictate specific
homing pathways.
Migration Down a Local Concentration Gradient
Situations in which leukocytes need to migrate down a
gradient towards their target could arise in diverse settings
where primary chemoattractants are produced by stimu-
lated host cells. Mechanisms that allow leukocytes to re-
main sensitive to new chemotactic signals, even when they
are at a local peak in the concentration of one agonist, could
permit cells to progress from one gradient source to an-
other rather than remaining at the peak of the first gradi-
ent they encounter. For example, leukocytes recruited
from the blood by endothelial cell–derived attractants may
subsequently need to migrate away from the endothelial
agonist source towards their target within a tissue.
In this study, we find a wide range of circumstances in
which neutrophils can indeed migrate down a functional
gradient of one chemoattractant in response to a second,
more distant gradient. As might have been predicted from
the hierarchy of chemoattractant receptors (discussed be-
low), neutrophils can migrate down a gradient of IL-8 or
LTB4 toward the dominant attractants fMLP and C5a. In
vivo, this behavior might permit cells to migrate away
from a regulatory cell recruiting neutrophils towards a
bacterium or immune complex. In addition, however, neu-
trophils can migrate down an IL-8 gradient towards LTB4;
surprisingly, the converse is also true. This indicates that
inhibition of the proximal agonist responses by the distant
one is not required for cells to migrate down a local gradi-
ent. Moreover, cells can be recruited “downhill” away from
an agonist source over an enormous range of concentra-
tions, spanning several orders of magnitude around the
EC50 for chemotaxis.
When the proximal gradient has a high mean concentra-
tion, it may provoke only a weak orienting signal due to
receptor saturation, homologous desensitization, and/or
receptor sequestration. When the nearby gradient has a
low mean concentration (with few receptors occupied),
cells may ignore it in favor of the distant gradient because
the slope and concentration range of the distant gradient
are more compelling (i.e., because the distant source forms
a gradient in a more optimal range for the cell’s gradient
detection mechanism). Any degree of homologous desen-
sitization to the primary agonist could also contribute to
dominance of the response to the distant gradient. More
difficult to understand is the ability of cells to migrate even
against a proximal gradient that, in the absence of the dis-
tant agonist, would be ideal for inducing reorientation and
reverse migration. We hypothesize that directional persis-
tence in this context may reflect a more efficient or rapid
adaptation of the migrating cell to increasing (distal ago-
nist) vs. decreasing (proximal agonist) attractant concen-
trations. Whatever the mechanisms involved, the ability of
neutrophils to migrate down a gradient of one agonist to-
wards a distant agonist, even in the absence of receptor
cross-inhibition, suggests the potential for cells to migrate
along a series of gradients in sequence.
Migration beyond a Threshold High Dose
of Chemoattractant
To attract cells over long distances, a target site must gen-
erate enough attractant for those cells to detect. Cells mi-
grating towards such a potent source, however, may not
reach the source, because as they approach they will even-
tually reach a saturating agonist concentration, beyond
which they lose the capacity to orient. This is likely due to
receptor saturation and/or receptor desensitization. We
have shown that leukocytes migrating up a gradient into
disorienting agonist concentrations retain the capacity to
resume directional migration in response to a gradient of a
different agonist. Thus, two attractants specific for the
same cell, rather than simply being redundant, may func-
tion together to recruit leukocytes. For example, a target
expressing multiple attractants at different levels may be
able to attract leukocytes from a greater distance than if it
were merely producing a single attractant alone. This may
represent an important advantage in regulatory cell re-
cruitment of leukocytes during inflammation; it may also
help explain the almost universal observation that acti-
vated stromal cells, as well as infiltrating leukocytes, char-
acteristically secrete multiple induced chemoattractant cy-
tokines concurrently.
Step-by-step Navigation through Sequential 
Chemotactic Fields
A major advantage of a system with multiple receptor–
ligand pairs is the potential to mix-and-match the attrac-
tants to create different homing pathways, thereby en-
hancing the specificity targeting and the number of targeting
choices. This would be possible if agonists could be “strung
together” into different homing sequences, which leuko-
cytes could follow by migrating first towards one agonist,
and then to a subsequent agonist, and so on. Our experi-
ments indicate that neutrophils can indeed migrate along a
gradient of one agonist, and then turn towards a more dis-
tant agonist source presented at a 908 angle to arrive at a
specific target site. Interestingly, when two sources of the
same agonist are presented in this configuration, cells do
not arrive in the target zone; two distinct agonists are re-
quired. This phenomenon may reflect the combined gradi-
ent shape perceived when a single agonist is used, since
neutrophils will always see the closest (central) source as
“uphill.” Even though the highest agonist concentration
may also be towards the central well when different ago-
nists are used, neutrophils respond completely differently
in this situation, eventually turning away from the first ag-
onist source to respond to the second. In this case, the
strength of the orienting signal from the first agonist may
progressively decrease due to homologous desensitization
or progressive receptor saturation as the migrating cells
approach the primary (central) well; sensitivity to the sec-The Journal of Cell Biology, Volume 139, 1997 1358
ondary agonist would be retained, however, so that its ori-
enting signal would eventually dominate as the migrating
cell is drawn within range. The turning behavior of neutro-
phils in this model emphasizes that, as in the previous case
of neutrophil recruitment beyond an inhibitory high dose
agonist barrier, two distinct chemoattractants presented in
sequence can elicit strikingly different homing patterns
than those elicited by any agonist alone (even when pre-
sented in the same spatial array). We conclude that mul-
tiple agonist–receptor pairs can be engaged in sequence
during leukocyte navigation, with resulting potential for en-
hanced versatility and selectivity in leukocyte targeting.
The Stop Signal
The experiments outlined above demonstrate that neutro-
phils migrate in sequence from one agonist source to an-
other. How then do cells arrive and remain at appropriate
final target sites? In many physiologic situations, it is likely
that additional mechanisms such as contact guidance, reg-
ulated adhesion, or inhibitory signals may determine the
final arrest of navigating cells. However, chemoattractants
can also play definitive roles in this context; as mentioned
in the Introduction, previous studies have shown that neu-
trophil response to regulatory attractants such as LTB4 or
IL-8 can be suppressed in the presence of uniform fields of
C5a and fMLP, agonists that define physiologic end tar-
gets for these professional phagocytes (i.e., immune com-
plexes that fix complement and generate C5a, or bacteria
or dying cells releasing formyl peptides). This inhibitory
effect of fMLP and C5a on regulatory agonist responses is
not due to toxicity, as we have previously shown in trans-
well assays that relatively low concentrations of formyl
peptides, within the range capable of supporting migration
in response to a gradient of formyl peptide itself, can com-
pletely suppress migratory responses to IL-8 gradients (4).
In the present studies as well, neutrophils’ ability to orient
towards a distant agonist is constrained by the dominance
of these end-target agonists, thus providing an exception
to the rule of sequential responses. In contrast to the abil-
ity of cells to migrate away from the regulatory agonist
source towards any distant secondary attractant, cells do
not migrate away from a strong fMLP or C5a source. In
the presence of mechanisms that maintain chemotactic re-
sponsiveness to sequential gradients, hierarchical cross-
inhibition of responses to certain agonists can be viewed as
an important mechanism for ensuring cells’ final naviga-
tion to their appropriate targets. Once neutrophils clear
the source of a dominant agonist (e.g., by phagocytosis of
bacteria) they may again be free to respond to regulatory
cell–derived or more distant end target attractants.
The ability of N-formyl peptides and C5a to inhibit
chemotactic responses to regulatory agonists is thought to
reflect the phenomenon of heterologous receptor desensi-
tization (4, 12). Stimulation of N-formyl peptide or C5a re-
ceptors induces phosphorylation of the IL-8 receptor, for
example, with associated functional uncoupling of the re-
ceptor from its signaling apparatus (17, 20). In the context
of leukocyte trafficking, it is worth emphasizing that the
formyl peptide and C5a receptors are the only receptors
known to mediate heterologous desensitization: none of
the tested chemokine or lipid attractant receptors exam-
ined to date appear to support uncoupling of heterologous
responses. Thus it is likely that the diverse family of
chemokines and their receptors can participate as interme-
diates in multistep cellular navigation, as illustrated here
for the chemoattractants LTB4 and IL-8.
Implications for the Combinatorial Regulation of 
Leukocyte Migration
Several years ago, we proposed that the interaction of cir-
culating lymphocytes or other leukocytes with endothelial
cells at sites of leukocyte recruitment could be determined
combinatorially. In other words, mixing and matching dif-
ferent combinations of the receptor–ligand pairs available
to mediate the sequential steps (contact initiation through
microvillus receptors, rolling, activation, and activation-
dependent arrest) involved in leukocyte–endothelial cell
recognition (3). The experiments described here extend
the concept of multistep trafficking to the arena of chemo-
tactic responses of leukocytes. They imply the potential
for combinatorial control of cellular targeting by associa-
tion of different receptors and agonists supporting the
step-by-step navigation of leukocytes through chemoat-
tractant arrays within tissues.
The implications of this model can be considered in the
context of a hypothetical scenario, illustrated in Fig. 8, in
which leukocyte recruitment from the blood vascular en-
dothelium to a defined tissue target is directed by three
chemoattractant sources operating in sequence. In the first
step, endothelial-associated agonist(s) (Fig. 8, A), which
may have played a role in leukocyte arrest from the blood,
support chemokinetic locomotion of the leukocyte on the
endothelium and potentially transendothelial migration.
In the second step, cells are recruited into the surrounding
tissues, away from the vessel wall, by a strong attractant
gradient (Fig. 8, B), which might be derived from an over-
lying stimulated epithelial surface. Cells migrating up this
gradient will eventually enter saturating, disorienting con-
centrations of the epithelial-derived agonist, allowing re-
orientation and entry into the target zone in response to a
Figure 8. Combinatorial reg-
ulation of chemotaxis. Leu-
kocyte homing during step-
by-step navigation is deter-
mined by the combination
and sequence of agonists and
receptors engaged. In this ex-
ample, a cell requires recep-
tor a to acquire motile prop-
erties and transmigrate through the endothelium in response to
agonist A; receptor b to respond to a gradient from an overlap-
ping epithelial surface that draws the cell into the tissue; and re-
ceptor c to detect a signal from its end target, and migrate there.
Only cells displaying all three receptors can successfully home to
the target region. The same receptors and agonists, displayed in
different patterns and/or in combination with other receptors,
could participate in a variety of different leukocyte targeting sce-
narios. This schematic emphasizes that simultaneous expression
of multiple receptors is required for homing, and demonstrates
how receptors that are displayed relatively indiscriminately (by
overlapping subsets of leukocytes) can elicit a specific homing
pattern when used in combination.Foxman et al. Combinatorial Control of Leukocyte Chemotaxis 1359
local chemoattractant (Fig. 8, C). Only those cells express-
ing receptors for all three agonists (Fig. 8, a, b, and c) will
successfully localize to the target.
If, within this scenario, a single agonist is used at each
step, and hypothetically four distinct receptor–agonist pairs
can be substituted at each step, then it follows that 4 3 4 3
4 5 64 independent leukocyte targeting scenarios can be
generated from only 12 chemoattractant receptor–agonist
combinations. Moreover, the combinatorial possibilities
will increase both with the number of differentially regu-
lated receptors that are available for substitution at each
step, and (in more complicated scenarios) with the number
of steps involved.
However, as mentioned above, chemoattractant recep-
tors on leukocytes, and their agonists in host stromal cells,
tend to be expressed in overlapping rather than mutually
exclusive patterns. Additionally, chemoattractant gradi-
ents within tissues must overlap spatially for migrating
cells to make the transition from one step to the next.
These features undoubtedly contribute to the resiliency of
cellular targeting in settings of altered agonist expression
or function, but at the same time they may limit the opera-
tional specificity at any one step. In this context, another
important implication of a multistep model is that the
specificity of the overall process can greatly exceed that of
any of its individual steps. Thus, in our hypothetical sce-
nario, if neutrophils were three times more likely than
lymphocytes to respond to the endothelial-associated ago-
nists mediating step 1, twice as likely to migrate into the
tissue in response to the chemoattractant profile available
at step 2, and five times more efficiently attracted at step 3,
then 30 (5 3 2 3 3) times more neutrophils should arrive
at the final target site.
These considerations illustrate the potential power of
multistep chemotaxis for regulating the segregation and
specific homing of leukocytes (and other cells) in the con-
text of complex agonist fields that are likely to be the
norm in vivo. Within this model the multiplicity of chemo-
attractant receptors on most leukocytes, far from implying
a lack of selectivity due to redundancy of responses, would
instead be essential for efficient and selective navigation
through sequential gradients. Moreover, the operation of
several steps in sequence, each potentially mediated by
only one or a few receptor agonist pairs, also suggests that
therapeutic intervention into the overall process of leuko-
cyte homing may be possible by interfering with any of a
number of different chemoattractant–receptor pairs.
Conclusion
In conclusion, leukocytes have the capacity to respond se-
quentially to chemoattractants, making possible a step-
by-step navigation through complex chemoattractant fields.
We have modeled this multistep migration through a sim-
ple in vitro chemoattractant array, demonstrating that se-
quential migration through two spatially distinct attractant
fields can target leukocytes in a unique fashion deter-
mined both by the nature and sequence of attractants. The
step-by-step model of leukocyte targeting provides a com-
binatorial mechanism whereby multiple attractants can
participate to guide leukocyte subsets to their unique des-
tinations within tissues, and suggests that rather than being
redundant, each of the many chemoattractant receptors
expressed on leukocyte surfaces may contribute to the ver-
satility and efficiency of leukocyte targeting in vivo.
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